Meso-jejunal lymph node dissection has a survival benefit in patients with remnant gastric cancer

Article Surgery

Comparison of long-term outcomes after robotic versus laparoscopic radical gastrectomy: a propensity score-matching study

Jin-Tao Li et al.

Summary: This study compared the outcomes and long-term results of robotic radical gastrectomy and laparoscopic radical gastrectomy. The study found no significant differences in 3-year overall survival and 3-year relapse-free survival between the two groups. Robotic radical gastrectomy can achieve results comparable to laparoscopic surgery.

SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2022)

Add to Collection

Article Oncology

Appropriate Lymph Node Dissection Sites for Cancer in the Body and Tail of the Pancreas: A Multicenter Retrospective Study

Kimitaka Tanaka et al.

Summary: This study evaluated the frequency and patterns of lymph node metastasis in patients with pancreatic body-tail cancers to determine the optimal lymph node dissection area for distal pancreatectomy. The study found that patients with pancreatic body cancer tumors showed no metastasis to the splenic hilum lymph node, suggesting that spleen-preserving pancreatectomy might be feasible for these patients.

CANCERS (2022)

Add to Collection

Article Surgery

Index of estimated benefit from lymph node dissection for stage I-III transverse colon cancer: an analysis of the JSCCR database

Hiroshi Sawayama et al.

Summary: This study aimed to identify high-risk patients for lymph node metastasis (LNM) in transverse colon (TC) cancer and evaluate the benefit of lymph node dissection. The presence of main LNM was associated with deep invasion, elevated carcinoembryonic antigen (CEA) levels, or tumor type 3. High-risk TC cancer patients had an estimated benefit from lymph node dissection (IEBLD) of over 5 for the main lymph node.

LANGENBECKS ARCHIVES OF SURGERY (2022)

Add to Collection

Article Oncology

Japanese gastric cancer treatment guidelines 2018 (5th edition)

GASTRIC CANCER (2021)

Add to Collection

Article Oncology

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2018

Seri Hong et al.

Summary: The study presents national cancer statistics and trends in Korea for 2018, covering incidence, mortality, survival, and prevalence rates. Overall, cancer incidence rates increased annually by 3.3% from 1999 to 2012, then decreased by 5.4% annually from 2012 to 2015, followed by insignificant changes. Meanwhile, cancer mortality rates have been decreasing since 2002, with a more rapid decline in recent years.

CANCER RESEARCH AND TREATMENT (2021)

Add to Collection

Article Oncology